KOSMOS BIOTHERAPEUTICS
Kosmos Biotherapeutics a preclinical-stage biopharmaceutical company developing an astrobiological therapeutic platform focused on the treatment of post-evolutionary disease in zero-gravity celestial settings.
KOSMOS BIOTHERAPEUTICS
Industry:
Biotechnology Medical Therapeutics
Founded:
2010-01-01
Address:
Cambridge, Massachusetts, United States
Country:
United States
Status:
Active
Similar Organizations
Palisade Therapeutics
Palisade Therapeutics develops therapeutics-based products for the treatment of neurological diseases.
Rimon Therapeutics
Rimon Therapeutics develops Theramers, a therapeutic polymer to treat chronic wounds.
More informations about "Kosmos Biotherapeutics"
Kosmos Biotherapeutics Company Profile 2024: Valuation, Funding ...
When was Kosmos Biotherapeutics founded? Kosmos Biotherapeutics was founded in 2010. Where is Kosmos Biotherapeutics headquartered? Kosmos Biotherapeutics is headquartered …See details»
Kosmos Biotherapeutics - Company Profile and News
Kosmos Biotherapeutics operates as a preclinical-stage biopharmaceutical company. The Company provides research into zero-gravity settings for astrobiological therapeutic platforms …See details»
Crystal Ball Ventures Investor Profile: Portfolio & Exits - PitchBook
Kosmos Biotherapeutics: 01-Mar-2021: 000000000 00000000: To view Crystal Ball Ventures’s complete exits history, request access » Crystal Ball Ventures Investments by Industry, Year, …See details»
NASA Bioventures Investor Profile: Portfolio & Exits - PitchBook
Kosmos Biotherapeutics: 04-Jan-2010: Biotechnology: Generating Revenue: To view NASA Bioventures’s complete investments history, request access » Want detailed data on 3M+ …See details»
What does kosmos biotherapeutics mean? - Definitions.net
What does kosmos biotherapeutics mean? Information and translations of kosmos biotherapeutics in the most comprehensive dictionary definitions resource on the web. LoginSee details»
Nationwide precision oncology pilot study: KOrean Precision …
Oct 1, 2024 Organization of the central molecular tumor board (cMTB) ... KOSMOS established a nationwide cMTB and demonstrated its effective operation in the treatment of advanced or …See details»
Kosmos Biotherapeutics - Crunchbase
Kosmos Biotherapeutics develops an astrobiological therapeutic platform for the treatment of post-evolutionary diseases.See details»
Kosmos Biotherapeutics Inc Company Profile, Financial and …
DigitGaps report on Kosmos Biotherapeutics Inc delivers a detailed in-depth and comprehensive insights of the company, its history, corporate strategy, its businesses and structures, and …See details»
Nationwide precision oncology pilot study: KOrean Precision …
Sep 20, 2024 KOSMOS had three different treatment options: tier 1, the therapeutic use of IMPs outside their approved indication as an expanded access program including: alectinib, …See details»
Rimon Therapeutics - Crunchbase
Rimon Therapeutics develops Theramers, a therapeutic polymer to treat chronic wounds.See details»
Eurofins Discovery
In 2024, the biotherapeutics industry continued its trajectory of changing the landscape of disease treatments for patients. To better understand the industry trends, we sat down with Dr. …See details»
The Year in Review: Biotherapeutics in 2024 and a Look Ahead to …
Dec 12, 2024 In 2024, the biotherapeutics industry continued its trajectory of changing the landscape of disease treatments for patients. The year kicked off with a landmark approval of …See details»
Biotherapeutic products - World Health Organization (WHO)
WHO published ‘Quality control of biologicals produced by recombinant DNA techniques’ in 1983 (Bulletin of the World Health Organization, 61). The article reviewed the application of …See details»
Biomanufacturing partnership boosts Canada’s life-saving …
Sep 13, 2021 The Ottawa Hospital’s Biotherapeutics Manufacturing Centre (BMC) is the most experienced and successful facility of its kind in Canada, having manufactured more than a …See details»
Apsara Therapeutics - Crunchbase
Apsara Therapeutics develops antibody therapies for the treatment of neuromyelitis optica.See details»
Developing Biotherapeutics in the New Decade - PMC
We selected original research articles and reviews on bioprocessing, developability and manufacturability of biologics, formulation and process development, and immunogenicity …See details»
Biologic and Radiopharmaceutical Drugs Directorate - Canada
The Centre for Blood, Blood Products and Biotherapeutics (CBBB) is responsible for the regulatory and scientific evaluation of a wide range of biologic products in the domain of …See details»
Nima Farzan, MBA - Latigo Biotherapeutics
Nima serves as the Chief Executive Officer at Latigo Biotherapeutics, bringing more than two decades of leadership experience in the biopharmaceutical industry. ... During his time at …See details»
Strategies for extending the half-life of biotherapeutics: successes ...
1. Introduction. Compared with the early days of biopharmaceutical drug development, starting with recombinant human insulin and human growth hormone (hGH) more than 40 years ago …See details»